Pleine Vie on MSN8mon
Ce médicament ne sera bientôt plus disponible en vente libre, l'ANSM déplore un "mésusage"
Dans les prochains jours, ce médicament antiallergique ... compter du 10 juillet 2024. Cette décision a été annoncée le 27 ...
Nasdaq22d
The Committee for Medicinal Products for Human Use (CHMP) reaffirms positive opinion for Lecanemab in early Alzheimer's disease in the EU
Following CHMP's reaffirmation, after having considered the additional information requested by the European Commission (EC), the EC will resume the decision-making process for lecanemab's ...
Nasdaq22d
AbbVie's Upadacitinib Gets Positive CHMP Opinion For Treatment Of Adults With Giant Cell Arteritis
(RTTNews) - AbbVie (ABBV) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted ... final European Commission decision is expected in the ...